SIMI, LISA
 Distribuzione geografica
Continente #
NA - Nord America 3.539
EU - Europa 2.721
AS - Asia 488
OC - Oceania 29
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.790
Nazione #
US - Stati Uniti d'America 3.535
PL - Polonia 1.248
RU - Federazione Russa 599
IT - Italia 199
IE - Irlanda 180
SE - Svezia 168
HK - Hong Kong 136
SG - Singapore 113
CN - Cina 98
DE - Germania 91
UA - Ucraina 66
CH - Svizzera 56
FI - Finlandia 46
IN - India 46
JO - Giordania 45
AU - Australia 29
VN - Vietnam 22
GB - Regno Unito 18
FR - Francia 13
TR - Turchia 13
ID - Indonesia 12
AT - Austria 11
BE - Belgio 9
CI - Costa d'Avorio 9
NL - Olanda 9
CA - Canada 4
ES - Italia 4
SC - Seychelles 3
RO - Romania 2
TW - Taiwan 2
BY - Bielorussia 1
EE - Estonia 1
EU - Europa 1
IR - Iran 1
Totale 6.790
Città #
Warsaw 1.248
Santa Clara 818
Fairfield 424
Chandler 283
Ashburn 246
Woodbridge 195
Seattle 186
Dublin 180
Cambridge 161
Houston 148
Wilmington 140
Jacksonville 112
Hong Kong 96
Singapore 93
Ann Arbor 70
Florence 67
Altamura 62
Lawrence 60
Bern 54
Princeton 51
Beijing 38
Boardman 38
Boston 33
Melbourne 28
Mumbai 26
New York 26
Kent 22
Shanghai 22
Bremen 21
Buffalo 20
Medford 20
San Diego 20
Dong Ket 19
Pune 17
Izmir 12
Jakarta 12
Vienna 11
Yubileyny 10
Abidjan 9
Brussels 9
Falls Church 9
Norwalk 9
Los Angeles 8
Milan 7
Phoenix 7
Hillsboro 6
Moscow 6
Redwood City 6
Arezzo 4
Auburn Hills 4
Barcelona 4
Fuzhou 4
Hefei 4
Verona 4
Amsterdam 3
Andover 3
Detroit 3
Frankfurt Am Main 3
Helsinki 3
Nanjing 3
Reggio Calabria 3
Salerno 3
Toronto 3
Brescia 2
Dearborn 2
Dordrecht 2
Fontebuona 2
Kilburn 2
Kunming 2
Manduria 2
Nanchang 2
Pisa 2
Portland 2
Scandicci 2
Secaucus 2
Taipei 2
Trumbull 2
Washington 2
Afa 1
Baotou 1
Botosani 1
Caserta 1
Chengdu 1
Dongguan 1
Frankfurt am Main 1
Genoa 1
Hangzhou 1
Harker Heights 1
Hengshui 1
Hyderabad 1
Isfahan 1
Jinan 1
Lachine 1
Lappeenranta 1
Latina 1
London 1
Mcallen 1
Modena 1
Mountain View 1
Munich 1
Totale 5.268
Nome #
Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers 302
Influence of 17q gain and promoter polymorphisms on mRNA expression of somatostatin receptor type 2 in neuroblastoma. 258
Seladin-1 expression is regulated by promoter methylation inadrenal cancer 248
High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer. 242
Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR. 237
SPIDIA-DNA: an External Quality Assessment for the pre-analytical phase of blood samples used for DNA-based analyses. 231
SPIDIA-RNA: second external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses. 229
KIT genetic alterations in anorectal melanomas. 220
Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer 216
null 196
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. 160
Analytical evaluation of an NGS testing method for routine molecular diagnostics on melanoma formalin-fixed, paraffin-embedded tumor-derived DNA 148
Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: relationship to estrogen and progesterone receptor status. 146
Denosumab treated giant cell tumour of bone: A morphological, immunohistochemical and molecular analysis of a series 141
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 141
GM1 gangliosidosis: molecular analysis of nine patients and development of an RT-PCR assay for GLB1 gene expression profiling. 141
Monitoring the susceptibility to oseltamivir of Influenza A(H1N1) 2009 virus by nested-PCR and pyrosequencing during the pandemic and in the season 2010-2011. 139
Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations 133
Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer. 133
Atypical Spitzoid melanocytic tumors: a morphological,mutational, and FISH analysis 131
The use of COLD-PCR and High Resolution Melting Analysis improves the limit of detection of KRAS and BRAF mutations in colorectal cancer 129
Phenotype variability of neural crest-derived tumours in six Italian families segregating the same founder SDHD mutation Q109X. 128
Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer. 127
Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue 126
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 126
Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone. 126
Tankyrase, a positive regulator of telomere elongation, is over expressed in human breast cancer. 125
SPIDIA-RNA: First external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses. 125
An Italian Program of External Quality Control for Quantitative Assays Based on Real-Time PCR with Taq-Man Probes. 124
Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma. 120
Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis. 119
BRAFV600E detection in melanoma is highlyimproved by COLD-PCR. 119
Implementation of a companion diagnostic in the clinical laboratory: The BRAF example in melanoma 116
SDH mutations in patients affected by paraganglioma syndromes: a personal experience. 115
Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection. 114
BRAF and KIT somatic mutations are present in amelanotic melanoma. 112
Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI. 109
Unbalanced GLA mRNAs ratio quantified by real-time PCR in Fabry patients' fibroblasts results in Fabry disease. 103
Protective effect of TGFß3 on the irradiated small instestine of mice. 92
Clodronate acts on human osteoclastic cell proliferation, differentiation and function in a bioreversible manner 91
From clinical trials to clinical practice: predictors ofresponse to erlotinib in advanced non-small cell lung cancer patients pretreated with chemotherapy 90
Clodronate modulates osteoclastogenesis by ATP analog, adenosine 5-(b,g-dichloromethylene) triphosphate, in human cell of the osteoclastic lineage with no toxic 90
Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells 86
Uterine leiomyosarcomas express KIT protein but lack mutation(s) in exon 9 ofc-KIT. 85
The use of COLD-PCR and high-resolution melting analysis improbe the limito f detection of KRAS and BRAF mutations in colorectal cancer 83
The clinical role of PIK3CA mutations in colorectal cancer 77
Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. 70
Two novel H-RAS mutations identified in a child with anatypical spitzoid tumor. 64
Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients 56
Totale 6.839
Categoria #
all - tutte 16.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.759


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020563 0 0 0 0 0 0 109 161 111 65 98 19
2020/2021781 53 74 43 131 60 88 29 62 59 93 38 51
2021/2022353 18 28 49 5 13 20 17 18 19 13 65 88
2022/20231.068 78 210 42 111 75 180 114 53 108 4 24 69
2023/2024392 6 37 53 9 27 74 26 117 3 1 30 9
2024/20251.781 57 234 114 373 704 294 5 0 0 0 0 0
Totale 6.839